| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.21 | 7e-05 |